Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Kedudukan dalam Saham #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Harga Saham
$0.39
Modal Pasaran
$13.79M
Perubahan (1 hari)
-13.53%
Perubahan (1 tahun)
-68.80%
Negara
IL
Perdagangan NeuroSense Therapeutics Ltd. (NRSN)

Kategori

Sejarah pecahan saham untuk NeuroSense Therapeutics Ltd. (NRSN)
Saham NeuroSense Therapeutics Ltd. (simbol: NRSN) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 18, 2026.
Satu saham NRSN yang dibeli sebelum Aug 18, 2026 kini bersamaan dengan 0 saham NRSN.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE